Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.

Animals Cannabinoid Receptor Agonists / chemical synthesis Drug Development Humans Receptors, Cannabinoid / physiology Signal Transduction / physiology
Biased signaling Cannabinoid receptor Functional assays G protein-coupled receptor Synthetic cannabinoid receptor agonist

Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
11 2019
Historique:
received: 21 06 2019
accepted: 26 08 2019
pubmed: 1 9 2019
medline: 14 7 2020
entrez: 1 9 2019
Statut: ppublish

Résumé

Cannabinoid receptors type 1 (CB

Identifiants

DOI: 10.1016/j.bcp.2019.08.025 PMID: 31472128
pubmed: 31472128
pii: S0006-2952(19)30313-2
doi: 10.1016/j.bcp.2019.08.025
pii:
doi:

Substances chimiques

Cannabinoid Receptor Agonists 0
Receptors, Cannabinoid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

113623

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Elise Wouters (E)

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Jolien Walraed (J)

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Samuel D Banister (SD)

The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Camperdown, NSW 2050, Australia; School of Chemistry, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia.

Christophe P Stove (CP)

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium. Electronic address: christophe.stove@ugent.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Insights into biased signaling at cannabinoid...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hormones, substituts d'hormones et antagonistes d'hormones › Hormones › Modulateurs des récepteurs de cannabinoïdes › Agonistes des récepteurs de cannabinoïdes › Insights into biased signaling at cannabinoid...
questionsmedicales.fr › Techniques d'investigation › Développement de médicament › Insights into biased signaling at cannabinoid...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Insights into biased signaling at cannabinoid...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs couplés aux protéines G › Récepteurs de cannabinoïdes › Insights into biased signaling at cannabinoid...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Insights into biased signaling at cannabinoid...